Your browser doesn't support javascript.
loading
Conversion chemotherapy using cetuximab plus FOLFIRI followed by bevacizumab plus mFOLFOX6 in patients with unresectable liver metastases from colorectal cancer.
Uehara, Keisuke; Ishiguro, Seiji; Hiramatsu, Kazuhiro; Nishio, Hideki; Takeuchi, Eiji; Takahari, Daisuke; Yoshioka, Yuichiro; Takahashi, Yu; Ebata, Tomoki; Yoshimura, Kenichi; Muro, Kei; Nagino, Masato.
Affiliation
  • Uehara K; Division of Surgical Oncology, Department of Surgery, Nagoya Graduate School of Medicine, 65, Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.
Jpn J Clin Oncol ; 41(10): 1229-32, 2011 Oct.
Article in En | MEDLINE | ID: mdl-21840871
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Clinical Trials, Phase II as Topic / Liver Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Jpn J Clin Oncol Year: 2011 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Clinical Trials, Phase II as Topic / Liver Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Jpn J Clin Oncol Year: 2011 Document type: Article Affiliation country: Japan Country of publication: United kingdom